ERAS

ERASCA INC

CUSIP: 29479A108

Market Cap
-
Sector
-
Institutional Owners
0
Institutional Value
-

About

Erasca Inc. is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and commercializing therapies for the treatment of cancer. The company focuses on advancing a diverse pipeline of precision oncology candidates designed to target specific molecular pathways and tumor biology. Through these efforts, Erasca aims to provide meaningful clinical solutions for patients battling various forms of malignancies within the competitive biotechnology sector.

Institutional Holders

Loading...